Lynn Matrisian, PhD, MBA
The Pancreatic Cancer Action Network has announced Lynn Matrisian, PhD, MBA, as inaugural Chief Research Officer for the organization. Dr. Matrisian was promoted from Vice President of Scientific and Medical Affairs, where she has served since 2011.
“To meet our aggressive goal to double survival by 2020, we must expand our scientific and clinical endeavors,” said Julie Fleshman, JD, MBA, President and CEO of the Pancreatic Cancer Action Network. “Lynn’s vast knowledge of the organization and Doug’s fresh perspective will drive change for this deadly disease and move us closer to our goal.”
In her expanded role as Chief Research Officer, Dr. Matrisian will develop initiatives designed to transform pancreatic cancer outcomes. These initiatives include early detection approaches and the creation of novel biomarker-driven clinical trials.
Prior to joining the Pancreatic Cancer Action Network, Dr. Matrisian led a research laboratory dedicated to understanding cancer metastasis. She was the founding chair of the Department of Cancer Biology in the School of Medicine at Vanderbilt University; President of the American Association for Cancer Research; and a Special Assistant to the Director of the National Cancer Institute at the National Institutes of Health. She earned a PhD in molecular biology from the University of Arizona and an MBA from the Owen Graduate School of Management at Vanderbilt University. ■
